A commonly used regimen is a loading phase of 25 mg per week (subcutaneous injection) for 46 weeks, followed by a maintenance dose of around 2 mg every 12 weeks
If you have any questions about our supplements or whether ALA would be beneficial for you, please feel free to reach out to our expert staff
doi: 10.3389/fphar.2023.1147414 Received 18 January 2023 Accepted 22 February 2023 Published 02 March 2023 Volume 14 - 2023 Edited by Zhihao Liu, Dalian Medical University, China Reviewed by Ral Gonzalez Ojeda, University of Galway, Ireland Hang Liu, University of California, Los Angeles, United States Updates Copyright 2023 Pei, Pan, Wei and Hua
Use fewer milliliters to create a higher concentration, or more to create a lower concentration for smaller doses
This is the physiological birth of a trigger point taut band
Most of what's being talked about now is a lab-made version of a signal your body already uses, which is part of why these compounds tend to be well tolerated